Antiviral agent comprising RNA oligonucleotideDiscovery of Multi-purpose, RNA-based Immunotherapeutics
The present invention provides an antiviral agent comprising an RNA oligonucleotide having a particular sequence and structure. Specifically, when a cell line is treated with an RNA oligonucleotide having specific sequence and helical bend structure according to the present invention, the expression of interferon-β or ISG56 is increased and anti-viral activating is exhibited. Thus, a composition comprising the RNA oligonucleotide can be used as an antiviral agent
- Assignee
- KAIST
- Country
- US (United States)
- Application Date
- 2016-08-29
- Application Number
- 15310559
- Registration Date
- 2019-12-31
- Registration Number
- 10,519,452
- Appears in Collection
- CH-Patent(특허)
- Files in This Item
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.